Northern Trust’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.98M Sell
352,152
-35,410
-9% -$400K ﹤0.01% 2590
2025
Q1
$4.47M Buy
387,562
+21,392
+6% +$247K ﹤0.01% 2482
2024
Q4
$3.1M Sell
366,170
-13,205
-3% -$112K ﹤0.01% 2783
2024
Q3
$4.39M Buy
379,375
+46,680
+14% +$541K ﹤0.01% 2562
2024
Q2
$3.92M Buy
332,695
+14,827
+5% +$175K ﹤0.01% 2529
2024
Q1
$3.77M Sell
317,868
-8,628
-3% -$102K ﹤0.01% 2643
2023
Q4
$4M Buy
326,496
+51,278
+19% +$628K ﹤0.01% 2633
2023
Q3
$2.65M Buy
275,218
+13,602
+5% +$131K ﹤0.01% 2785
2023
Q2
$2.35M Buy
261,616
+25,503
+11% +$230K ﹤0.01% 2927
2023
Q1
$1.86M Sell
236,113
-5,850
-2% -$46K ﹤0.01% 2972
2022
Q4
$1.64M Sell
241,963
-2,733
-1% -$18.5K ﹤0.01% 3094
2022
Q3
$3.55M Buy
244,696
+478
+0.2% +$6.94K ﹤0.01% 2695
2022
Q2
$2.4M Sell
244,218
-3,458
-1% -$34K ﹤0.01% 2955
2022
Q1
$3.65M Sell
247,676
-7,233
-3% -$107K ﹤0.01% 2769
2021
Q4
$3.37M Buy
254,909
+21,169
+9% +$280K ﹤0.01% 2943
2021
Q3
$4.08M Sell
233,740
-8,093
-3% -$141K ﹤0.01% 2863
2021
Q2
$5.79M Buy
241,833
+13,163
+6% +$315K ﹤0.01% 2750
2021
Q1
$5.88M Sell
228,670
-574
-0.3% -$14.7K ﹤0.01% 2655
2020
Q4
$4.35M Sell
229,244
-9,652
-4% -$183K ﹤0.01% 2762
2020
Q3
$3.01M Sell
238,896
-3,297
-1% -$41.5K ﹤0.01% 2842
2020
Q2
$2.93M Buy
242,193
+52,910
+28% +$640K ﹤0.01% 2823
2020
Q1
$1.45M Buy
189,283
+3,514
+2% +$26.9K ﹤0.01% 3031
2019
Q4
$3.31M Buy
185,769
+7,248
+4% +$129K ﹤0.01% 2829
2019
Q3
$2.07M Buy
178,521
+104,691
+142% +$1.22M ﹤0.01% 3087
2019
Q2
$1.64M Buy
73,830
+32,930
+81% +$729K ﹤0.01% 3169
2019
Q1
$1.17M Buy
40,900
+172
+0.4% +$4.92K ﹤0.01% 3304
2018
Q4
$805K Buy
40,728
+10,034
+33% +$198K ﹤0.01% 3432
2018
Q3
$678K Buy
+30,694
New +$678K ﹤0.01% 3572
2016
Q4
Sell
-1,467
Closed -$9K 4198
2016
Q3
$9K Hold
1,467
﹤0.01% 4140
2016
Q2
$13K Sell
1,467
-7,618
-84% -$67.5K ﹤0.01% 4147
2016
Q1
$82K Sell
9,085
-1
-0% -$9 ﹤0.01% 3944
2015
Q4
$461K Hold
9,086
﹤0.01% 3532
2015
Q3
$454K Buy
9,086
+7,003
+336% +$350K ﹤0.01% 3520
2015
Q2
$209K Buy
+2,083
New +$209K ﹤0.01% 3775